Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is $1,151.16, with a 24-hour trading volume of $3.81M. The asset's market cap is $1.02T, after moving 0.20% in the last day.
Tokenized Eli Lilly And Co is trading at $1,154.44, with a tokenized market cap of $5.89M and a 24-hour trading volume of $1.56M. The tokenized asset has moved -0.10% in the past 24 hours.